Clinical trial
A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx Influenza A/B + RSV Test at Point of Care Testing Sites
NCT04288921 is registered in ClinicalTrials.gov with LumiraDx UK Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Study Conducted to Evaluate the Performance of the LumiraDx Influenza A/B + RSV Test at Point of Care Testing Sites
- Lead sponsor
- LumiraDx UK Limited
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 6, 2020
- Completion date
- March 2, 2020
- Enrollment
- 525 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.